Commercialization Updates. For any Calendar Year prior to the end of the ER Royalty Term, FDC Royalty Term or Proprietary Non-Donepezil FDC Royalty Term, as applicable, in which Forest or its Affiliates or Sublicensees is Commercializing a Product in the Field in the Territory, Forest shall, on [*] basis, provide Adamas with a reasonably detailed report describing such Commercialization activities completed since the last report and planned for the next [*], no later than [*]. Following the receipt of the first approval by the FDA of an NDA for the first Memantine-Donepezil FDC Product in the Field in the Territory, the Parties shall meet [*] during each Calendar Year to discuss the Commercialization of the Products in the Field [*].
Commercialization Updates. Impax shall, through the JMC (or directly, if JMC is terminated), keep Durect appropriately and routinely informed regarding progress with respect to its Commercialization of the Product in the Territory.
Commercialization Updates. AZ shall keep the JSC fully informed regarding the progress of all material commercialization activities for the Products in the Territory.
Commercialization Updates. Novartis shall keep MPAG reasonably informed of Novartis’, its Affiliates’ and their respective sublicensees’ Commercialization activities with respect to the Products by providing updates through the Governance Committee at least [***] per Calendar Year. Upon MPAG’s request (which may be made no more than [***] per Calendar Year) such updates shall include the amount of Net Sales of Products in each country in the Territory other than the Commercial Territories. 264813180 v3
Commercialization Updates. Legend shall keep Noile informed of its Commercialization of any Licensed Product and shall provide [***] updates to Noile summarizing progress in the Development and Commercialization of any Licensed Products in relation to which any Research and Development Plan has been completed. All such updates shall be considered Legend’s Confidential Information and, as between the Parties, shall be exclusively owned by Legend.
Commercialization Updates. CAMP4 will provide OPKO with an annual report summarizing its Commercialization activities for the Licensed Products in the Field in the Territory. Such reports will be Confidential Know-How of CAMP4 and subject to the terms of ARTICLE 11 (Confidentiality).
Commercialization Updates. Without limitation of Section 4.4.1, for the time period during which a Party is conducting Commercialization activities hereunder, such Party shall update the JCC at each regularly scheduled meeting of the JCC regarding its Commercialization activities with respect to the Licensed Products in the Licensed Field in the United States Each such update will summarize such Party’s significant Commercialization activities with respect to Licensed Products in the Licensed Field in the United States to the extent that such Party has the right to disclose such information to the other Party without violating any confidentiality or other obligations to any Third Party.
Commercialization Updates. On a [***] basis, for each applicable Licensed Product Directed To [***], beginning [***] for such Licensed Product in the Territory and ending upon [***], Sanofi will submit, in accordance with this Section 7.4 (Commercialization Updates) below, a [***] report [***]. Sanofi will submit each such report [***].
Commercialization Updates. At each meeting of the JCC, each Party will share with the JCC a summary regarding the activities conducted by or on behalf of such Party under each Co-Commercialization Program since the last JCC meeting, sufficient for the JCC to assess each Party’s progress under the Co-Commercialization Program. Each Party will also promptly provide notice to the other Party, through the JCC, of any significant Commercialization events under any Co-Commercialization Program that the reporting Party reasonably believes materially impacts the Commercialization activities of the other Party under such Co-Commercialization Program or otherwise under this Agreement or that such Party reasonably believes would be of interest to the other Party.
Commercialization Updates. (a) AstraZeneca Updates. Commencing in December 2019 and thereafter within 30 days following each of June 30 and January 1 of each Year to the extent of any updates, AstraZeneca will provide the JSC with a high-level summary regarding its Commercialization activities (including those activities set forth in the Commercialization Plan) with respect to the Products in the prior half-Year. Without limiting the foregoing, each such high-level summary will also [**]. In addition, no less frequently than once each Year, AstraZeneca will provide the JSC with its then-current Commercialization Plan with respect to the Products in the Territory. Ironwood may provide comments with respect to AstraZeneca’s Commercialization strategy through its representatives on the JSC, which AstraZeneca will consider in good faith.
